Effect and mechanism of bromodomain-containing protein 4 inhibitor JQ1 on formaldehyde solution induced inflammatory pain in mice

CHEN Ling LIU Zhi-wen YANG Bin ZHOU Xin XIE Zhi-yan ZENG Jia-yu ZHAO Ke-xin CAO Wen-yu ZHONG Xiao-lin

Acta Anatomica Sinica ›› 2022, Vol. 53 ›› Issue (4) : 412-417.

PDF(4008 KB)
Welcome to visit Acta Anatomica Sinica! Today is Chinese
PDF(4008 KB)
Acta Anatomica Sinica ›› 2022, Vol. 53 ›› Issue (4) : 412-417. DOI: 10.16098/j.issn.0529-1356.2022.04.002

Effect and mechanism of bromodomain-containing protein 4 inhibitor JQ1 on formaldehyde solution induced inflammatory pain in mice

  • CHEN  Ling1 LIU  Zhi-wen2  YANG  Bin2  ZHOU  Xin3  XIE  Zhi-yan ZENG  Jia-yu ZHAO  Ke-xin3  CAO  Wen-yu3* ZHONG  Xiao-lin1*
Author information +
History +

Abstract

Objective  To explore the expression and role of bromodomain-containing protein 4(BRD4) in spinal cord of mice which suffered inflammatory pain induced by formaldehyde solution.    Methods  Thirty-two ICR mice were randomly divided into normal saline group and formaldehyde injection 5 minutes, 30 minutes and 60 minutes groups, with 8 mice in each group. The expression of BRD4 protein and mRNA in spinal cord of mice in each group were detected by Western blotting (n=4/group) and Real-time PCR (n=4/group); 66 mice were randomly divided into formaldehyde injection group, vehicle (DMSO) plus formaldehyde injection group and 6.25, 12.5, 25 and 50 mg/kg JQ1 injection plus formaldehyde solution group, with 11 mice in each group. The effect of BRD4 inhibitor JQ1 on spontaneous pain in each group was observed (n=11/group); Immunohistochemistry (n=3/group), Real-time PCR (n=4/group) or Western blotting (n= 4/group) were used to detect the effects of 25 mg/kg JQ1 on the expression of c-fos and glutamate receptor 2(GluR2) in the spinal cord of model mice.    Results  The result  showed that levels of BRD4 protein (P<0.01) and mRNA in spinal cord increased significantly 30 min and 60 min after formaldehyde solution injection (P<0.05). The behavioral test showed that both 25 mg/kg and 50 mg/kg JQ1 administration could reduce the second phase spontaneous pain compared with the solvent (DMSO) group (P<0.05). Furthermore, immunohistochemistry and Real-time PCR result  showed that 25 mg/kg JQ1 injection could significantly reduce positive numbers (P<0.01) and high mRNA expression of c-fos in mouse spinal cord induced by formaldehyde solution (P<0.05), and the Western blotting result  showed that 25 mg/kg JQ1 administration could significantly reduce the expression of glutamate receptor GluR2 (P<0.001).     Conclusion  BRD4 may play an important role in the induction of central sensitization of inflammatory pain, and JQ1 may alleviate inflammatory pain behavior by inhibiting the formation of central sensitization of pain.

Key words

Bromodomain-containing protein 4 / Inflammatory pain / Central sensitization / Spinal cord /   / Western blotting /   / Mouse

Cite this article

Download Citations
CHEN Ling LIU Zhi-wen YANG Bin ZHOU Xin XIE Zhi-yan ZENG Jia-yu ZHAO Ke-xin CAO Wen-yu ZHONG Xiao-lin. Effect and mechanism of bromodomain-containing protein 4 inhibitor JQ1 on formaldehyde solution induced inflammatory pain in mice[J]. Acta Anatomica Sinica. 2022, 53(4): 412-417 https://doi.org/10.16098/j.issn.0529-1356.2022.04.002

References

[1]Wu T, Pinto HB, Kamikawa YF, et al. The BET family member BRD4 interacts with OCT4 and regulates pluripotency gene expression [J]. Stem Cell Rep, 2015, 4(3): 390-403.
[2]Schnepp RW, Maris JM. Targeting MYCN: a good BET for improving neuroblastoma therapy [J]. Cancer Discov, 2013, 3(3): 255-257.
[3]Tian B, Hosoki K, Liu ZQ, et al. Mucosal bromodomain-containing protein 4 mediates aeroallergen-induced inflammation and remodeling [J]. J Allergy Clin Immunol, 2019, 143(4):1380-1394.
[4]Andrieu GP, Shafran JS, Deeney JT, et al. BET proteins in abnormal metabolism, inflammation, and the breast cancer microenvironment [J]. J Leukoc Biol, 2018, 104(2): 265-274.
[5]White ME, Fenger JM, Carson WE. Emerging roles of and therapeutic strategies targeting BRD4 in cancer [J]. Cell Immunol, 2019, 337: 48-53.
[6]Filippakopoulos P, Qi J, Picaud S, et al. Selective inhibition of BET bromodomains [J]. Nature, 2010, 468(7327): 1067-1073.
[7]Leal AS, Williams CR, Royce DB, et al. Bromodomain inhibitors, JQ1 and I-BET 762, as potential therapies for pancreatic cancer [J]. Cancer Lett, 2017, 394: 76-87.
[8]Park S, Willingham MC, Qi J, et al. Metformin and JQ1 synergistically inhibit obesity-activated thyroid cancer [J]. Endocr Relat Cancer, 2018, 25(10): 865-877.
[9]Judith SV, Jesús AA, Xavier N, et al. BET protein inhibition regulates cytokine production and promotes neuroprotection after spinal cord injury [J]. J Neuroinflamm ation, 2019, 16(1): 124.
[10] Machado NJ, Sim?es AP, Silva HB, et al. Caffeine reverts memory but not mood impairment in a depression-prone mouse strain with up-regulated adenosine A 2A receptor in hippocampal glutamate synapses [J]. Mol Neurobiol, 2017, 54(2): 1552-1563.
[11] Hu XD, Ballo L, Pietila L, et al. BDNF-induced increase of PSD-95 in dendritic spines requires dynamic microtubule invasions [J]. J Neurosci, 2011, 31(43): 15597-15603.
[12] Erica K, Herre M, Ilana ZS, et al. BET protein Brd4 activates transcription in neurons and BET inhibitor Jq1 blocks memory in mice [J]. Nat Neurosci, 2015, 18(10): 1464-1473.

[13] Yaster M, Guan X, Petralia RS, et al. Effect of inhibition of spinal cord glutamate transporters on inflammatory pain induced by Formaldehyde solution and complete Freund’s adjuvant [J]. Anesthesiology, 2011, 114(2): 412-423.

[14] Hough LB, Rice FL. H3 receptors and pain modulation: peripheral, spinal, and brain interactions [J]. J Pharmacol Exp Ther, 2011, 336(1): 30-37.

[15] Bandopadhayay P, Bergthold G, Nguyen B, et al. BET bromodomain inhibition of MYC-amplified medulloblastoma [J]. Clin Cancer Res, 2014, 20(4): 912-925.
[16] Korb E, Herre M, Zucker SI, et al. BET protein Brd4 activates transcription in neurons and BET inhibitor Jq1 blocks memory in mice [J]. Nat Neurosci, 2015, 18(10): 1464-1473.
[17] Mele DA, Salmeron A, Ghosh S, et al. BET bromodomain inhibition suppresses TH17-mediated pathology [J]. J Exp Med, 2013, 210(11): 2181-2190.
[18] Jung KH, Das A, Chai JC, et al. RNA sequencing reveals distinct mechanisms underlying BET inhibitor JQ1-mediated modulation of the LPS-induced activation of BV-2 microglial cells [J]. J Neuroinflammation, 2015, 12: 36.
[19] Sartor GC, Powell SK, Brothers SP, et al. Epigenetic readers of lysine acetylation regulate cocaine-induced plasticity [J]. J Neurosci, 2015, 35(45): 15062-15072.
[20] Hsieh MC, Ho YC, Lai CY, et al. Bromodomain-containing protein 4 activates voltage-gated sodium channel 1.7 transcription in dorsal root ganglia neurons to mediate thermal hyperalgesia in rats [J]. Anesthesiology, 2017, 127(5): 862-877.
[21] Takahashi K, Yi H, Liu CH, et al. Spinal bromodomain-containing protein 4 contributes to neuropathic pain induced by HIV glycoprotein 120 with morphine in rats [J]. Neuroreport, 2018, 29(6): 441-446.
[22] Guerra B, Issinger OG. Protein kinase CK2 in human diseases [J]. Curr Med Chem, 2008, 15(19): 1870-1886.
PDF(4008 KB)

Accesses

Citation

Detail

Sections
Recommended

/